Low molecular weight heparins – should treatment doses be used in patients with renal impairment?

This updated Medicines Q & A reviews and summarise the evidence available for low molecular weight heparin (LMWH) treatment doses in renal impairment. It summarises ESC advice but states that more comparative data (between LMWHs and unfractionated heparin) are required.

Source:

Specialist Pharmacy Service